Spironolactone for heart failure - Spiraling out of control

被引:1
作者
Geraci, JM
Knowlton, AA
机构
[1] Vet Affairs Med Ctr, Cardiol Sect, Houston, TX 77030 USA
[2] Vet Affairs Med Ctr, Gen Internal Med Sect, Houston, TX 77030 USA
[3] Vet Affairs Med Ctr, Dept Med, VA HSR&D Field Program, Houston, TX 77030 USA
[4] Baylor Univ, Waco, TX 76798 USA
[5] Baylor Coll Med, Houston, TX 77030 USA
关键词
D O I
10.1378/chest.118.6.1522-a
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
引用
收藏
页码:1522 / 1523
页数:2
相关论文
共 9 条
[1]
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure [J].
Bristow, MR ;
Gilbert, EM ;
Abraham, WT ;
Adams, KF ;
Fowler, MB ;
Hershberger, RE ;
Kubo, SH ;
Narahara, KA ;
Ingersoll, H ;
Krueger, S ;
Young, S ;
Shusterman, N .
CIRCULATION, 1996, 94 (11) :2807-2816
[2]
β-blocker therapy for heart failure -: The evidence is in, now the work begins [J].
Califf, RM ;
O'Connor, CM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (10) :1335-1337
[3]
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure -: The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) [J].
Hjalmarson, Å ;
Goldstein, S ;
Fagerberg, B ;
Wedel, H ;
Waagstein, F ;
Kjekshus, J ;
Wikstrand, J ;
El Allaf, D ;
Vítovec, J ;
Aldershvile, J ;
Halinen, M ;
Dietz, R ;
Neuhaus, KL ;
Jánosi, A ;
Thorgeirsson, G ;
Dunselman, PHJM ;
Gullestad, L ;
Kuch, J ;
Herlitz, J ;
Rickenbacher, P ;
Ball, S ;
Gottlieb, S ;
Deedwania, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (10) :1295-1302
[4]
Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure - The PRECISE trial [J].
Packer, M ;
Colucci, WS ;
SacknerBernstein, JD ;
Liang, CS ;
Goldscher, DA ;
Freeman, I ;
Kukin, ML ;
Kinhal, V ;
Udelson, JE ;
Klapholz, M ;
Gottlieb, SS ;
Pearle, D ;
Cody, RJ ;
Gregory, JJ ;
Kantrowitz, NE ;
LeJemtel, TH ;
Young, ST ;
Lukas, MA ;
Shusterman, NH .
CIRCULATION, 1996, 94 (11) :2793-2799
[5]
WITHDRAWAL OF DIGOXIN FROM PATIENTS WITH CHRONIC HEART-FAILURE TREATED WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS [J].
PACKER, M ;
GHEORGHIADE, M ;
YOUNG, JB ;
COSTANTINI, PJ ;
ADAMS, KF ;
CODY, RJ ;
SMITH, LK ;
VANVOORHEES, L ;
GOURLEY, LA ;
JOLLY, MK .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (01) :1-7
[6]
The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].
Pitt, B ;
Zannad, F ;
Remme, WJ ;
Cody, R ;
Castaigne, A ;
Perez, A ;
Palensky, J ;
Wittes, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717
[7]
Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the survival and ventricular enlargement (SAVE) study [J].
Vantrimpont, P ;
Rouleau, JL ;
Wun, CC ;
Ciampi, A ;
Klein, M ;
Sussex, B ;
Arnold, JMO ;
Moye, L ;
Pfeffer, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) :229-236
[8]
Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure [J].
Whorlow, SL ;
Krum, H .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (08) :886-+